Want to see IN:TTKHLTCARE full AI Analyst Report?
TTKHLTCARE Stock Chart & Stats
₹1082.70
-₹40.65(-3.73%)
At close: 4:00 PM EDT
₹1082.70
-₹40.65(-3.73%)
Day’s Range― - ―
52-Week Range₹737.00 - ₹1,255.00
Previous CloseN/A
Volume18.95K
Average Volume (3M)82.00
Market Cap
₹14.48B
Enterprise Value₹1.34K
Total Cash (Recent Filing)₹9.36B
Total Debt (Recent Filing)₹243.78M
Price to Earnings (P/E)22.0
Beta0.80
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)46.48
Shares Outstanding14,130,333
10 Day Avg. Volume50
30 Day Avg. Volume82
Financial Highlights & Ratios
PEG Ratio-0.86
Price to Book (P/B)0.99
Price to Sales (P/S)1.29
P/FCF Ratio-41.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageVery low debt-to-equity (~2–3%) and a growing equity base provide durable financial flexibility, reducing solvency risk and preserving optionality for capex or M&A. This conservatism supports resilience through cyclical stress and underpins strategic investment capacity over months.
Diversified Healthcare And Consumer Product PortfolioA multi-segment product mix across prescription, OTC and consumer healthcare fosters durable revenue diversification and channel breadth. Brand and product variety reduce reliance on any single molecule or channel, supporting steadier sales and cross-selling opportunities over the medium term.
Generally Solid Profitability Margins HistoricallyConsistent mid-to-high single-digit net margins indicate underlying pricing power and cost control in normal years. This margin baseline provides a structural cushion to absorb cyclical input cost swings and helps protect long-term earnings potential if margins are restored.
Bears Say
Sustained Negative Operating And Free Cash FlowMulti-year negative OCF and FCF erode the firm's ability to self-fund growth or cover distributions despite low leverage. Persistent cash burn increases dependence on reserves or external funding, constraining strategic flexibility and raising medium-term liquidity and funding risks.
Recent Margin Compression In Latest YearA pronounced step-down in gross profit and EBITDA margins suggests structural cost, mix or pricing headwinds. If sustained, lower margins reduce internal cash generation and ROIC, making it harder to fund investments and weakening competitiveness over the coming quarters.
Earnings Volatility And Recent EPS DeclineA nearly 20% EPS decline and cited ROE volatility from an outsized 2023 profit indicate earnings are uneven and sensitive to one-off factors. Persistent earnings volatility complicates forecasting, undermines investor confidence, and can mask underlying operational weaknesses over several quarters.
TTK Healthcare Limited News
TTKHLTCARE FAQ
What was TTK Healthcare Limited’s price range in the past 12 months?
TTK Healthcare Limited lowest stock price was ₹737.00 and its highest was ₹1255.00 in the past 12 months.
What is TTK Healthcare Limited’s market cap?
TTK Healthcare Limited’s market cap is ₹14.48B.
When is TTK Healthcare Limited’s upcoming earnings report date?
TTK Healthcare Limited’s upcoming earnings report date is Aug 06, 2026 which is today.
How were TTK Healthcare Limited’s earnings last quarter?
Currently, no data Available
Is TTK Healthcare Limited overvalued?
According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued.
Does TTK Healthcare Limited pay dividends?
TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.97%. See more information on TTK Healthcare Limited dividends here
What is TTK Healthcare Limited’s EPS estimate?
TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TTK Healthcare Limited have?
TTK Healthcare Limited has 14,130,333 shares outstanding.
What happened to TTK Healthcare Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TTK Healthcare Limited?
Currently, no hedge funds are holding shares in IN:TTKHLTCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TTK Healthcare Limited
TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals division provides a range of herbal and allopathic formulations. Within consumer products, the company is responsible for marketing and distributing items such as Woodward's Gripewater, the EVA cosmetics line, and Good Home scrubbers and air fresheners. Its medical devices segment manufactures and supplies artificial heart valves, in addition to developing orthopedic implants and surgical instruments. Furthermore, TTK Healthcare produces and markets protective devices, including male contraceptives. The food segment specializes in manufacturing and selling processed food items like potato and cereal-based pellets. Notably, the company also engages in map and atlas printing and publishing through its 'Others' segment. Founded in 1958 and headquartered in Chennai, India, TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
GlaxoSmithKline Pharmaceuticals Limited
―
Sanofi India Limited
―
Sanofi Consumer Healthcare India Limited
―